glp-1 c elegans DIV-1/PolA2 Promotes GLP-1/Notch-Mediated Cellular Events in Caenorhabditis Germline loss in C. elegans

The trick is losing the weight gradually (which these medications help with) and then giving yourself that stabilization period before trying to conceive

Employers offering weight-loss coverage rose in 2026 from 17% in 2024 Canadian employers are broadening access to glucagon-like peptide-1 (GLP-1) drugs for weight loss, with the share offering that coverage rising to 37 percent in 2026 from 17 percent in 2024

GLP-1 receptor agonists have been shown to reduce major adverse cardiovascular events including cardiovascular death, heart attack, and stroke in patients with type 2 diabetes

FDA Drug Approval Decisions Expected in April 2026

Camilleri M, Bharucha AE, Di Lorenzo C, Hasler WL, Prather CM, Rao SS, et al

In JAMAs 2025 study, only 35% of initially-rejected prescriptions were resolved on the same day, and the median resolution time was 6 days (interquartile range 312 days) for those requiring multiple-day reviews ( [5] )